Management of Cyclical Menorrhagia with Prostaglandin Synthetase Inhibitor
article
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
Mefenamic acid significantly reduced menstrual bleeding duration and volume in patients with unexplained cyclical menorrhagia compared to placebo.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
A well controlled double blind prospective trial was undertaken to determine the efficacy of mefenamic acid in the treatment of menorrhagia. Eighty patients who had unexplained cyclical menorrhagia with secretory endometrium received mefenamic acid orally in a dose of 500 mg 8 hourly or a placebo tablet thrice daily starting from day-one of the cycle for 5 days or till cessation of menses. Mefenamic acid administration caused a statistically significant reduction in the number of days of bleeding from 9.7 +/- 3.1 days before treatment to 4.1 +/- 0.6 days after treatment. It also brought about significant reduction in the amount of bleeding in terms of number of pads used per day, that is from 15.2 +/- 3.1 before treatment to 6.5 +/- 0.02 after treatment. Eighty-six percent patients in the treatment group had control of menorrhagia with the drug compared to 20% in the control group without drugs and this difference was statistically significant. Mefenamic acid proved to be a potent and efficacious agent in the control of unexplained menorrhagia.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- An Objective Evaluation of Flurbiprofen and Tranexamic Acid in the Treatment of Idiopathic Menorrhagia via openalex
- Control of menorrhagia by the cyclo‐oxygenase inhibitors naproxen sodium and mefenamic acid via openalex
- Efficacy of mefenamic acid in patients with a complaint of menorrhagia. via openalex
- Increased uterine prostaglandin E receptors in menorrhagic women via openalex
- Levels of prostaglandins in human endometrium during the normal menstrual cycle via openalex
- Prostaglandins in the human uterus: An interaction between endometrium and myometrium via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- STUDIES IN THE INVOLVEMENT OF PROSTAGLANDINS IN UTERINE SYMPTOMATOLOGY AND PATHOLOGY via openalex
- W2059349398 via openalex
- W2083717098 via openalex
- W2087776844 via openalex
- W2152479458 via openalex
- W2431968125 via openalex
- W6607729374 via openalex
- W39552743 via openalex
- W6718143281 via openalex
- W191591924 via openalex
- W1572362848 via openalex
- W1964830004 via openalex
- W1972893700 via openalex
- W1980793242 via openalex
- W1983356056 via openalex
- W2002213869 via openalex
- W2048969852 via openalex
Cited by (12)
- Variation of outcome reporting in studies of interventions for heavy menstrual bleeding: a systematic review 2022
- NSAIDs for heavy menstrual bleeding 2021
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2019
- Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding 2013
- Heavy menstrual flow: current and future trends in management. 2013
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 2007
- Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users 2006
- Abnormal Uterine Bleeding: A Management Algorithm 2006
- Benefits and Risks of Pharmacological Agents Used for the Treatment of Menorrhagia 2004
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding 1998
- Treatment of Menorrhagia 1992
- 8 Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders 1992
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK